These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Enhancement and inhibition by 2'-O-hydroxyethyl residues of gene targeting mediated by triple helix forming oligonucleotides. Kundu M; Nagatsugi F; Majumdar A; Miller PS; Seidman MM Nucleosides Nucleotides Nucleic Acids; 2003 Oct; 22(10):1927-38. PubMed ID: 14609232 [TBL] [Abstract][Full Text] [Related]
5. The development of bioactive triple helix-forming oligonucleotides. Seidman MM; Puri N; Majumdar A; Cuenoud B; Miller PS; Alam R Ann N Y Acad Sci; 2005 Nov; 1058():119-27. PubMed ID: 16394131 [TBL] [Abstract][Full Text] [Related]
6. Minimum number of 2'-O-(2-aminoethyl) residues required for gene knockout activity by triple helix forming oligonucleotides. Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM Biochemistry; 2002 Jun; 41(24):7716-24. PubMed ID: 12056903 [TBL] [Abstract][Full Text] [Related]
7. Site-specific gene modification by PNAs conjugated to psoralen. Kim KH; Nielsen PE; Glazer PM Biochemistry; 2006 Jan; 45(1):314-23. PubMed ID: 16388608 [TBL] [Abstract][Full Text] [Related]
11. A triple-helix forming oligonucleotide targeting genomic DNA fails to induce mutation. Reshat R; Priestley CC; Gooderham NJ Mutagenesis; 2012 Nov; 27(6):713-9. PubMed ID: 22914677 [TBL] [Abstract][Full Text] [Related]
12. Targeted genome modification via triple helix formation. Kalish JM; Glazer PM Ann N Y Acad Sci; 2005 Nov; 1058():151-61. PubMed ID: 16394134 [TBL] [Abstract][Full Text] [Related]
13. Targeting chromosomal sites with locked nucleic acid-modified triplex-forming oligonucleotides: study of efficiency dependence on DNA nuclear environment. Brunet E; Corgnali M; Cannata F; Perrouault L; Giovannangeli C Nucleic Acids Res; 2006; 34(16):4546-53. PubMed ID: 16951289 [TBL] [Abstract][Full Text] [Related]
14. High-efficiency triple-helix-mediated photo-cross-linking at a targeted site within a selectable mammalian gene. Vasquez KM; Wensel TG; Hogan ME; Wilson JH Biochemistry; 1996 Aug; 35(33):10712-9. PubMed ID: 8718860 [TBL] [Abstract][Full Text] [Related]
15. Targeted cross-linking of the human beta-globin gene in living cells mediated by a triple helix forming oligonucleotide. Shahid KA; Majumdar A; Alam R; Liu ST; Kuan JY; Sui X; Cuenoud B; Glazer PM; Miller PS; Seidman MM Biochemistry; 2006 Feb; 45(6):1970-8. PubMed ID: 16460044 [TBL] [Abstract][Full Text] [Related]
16. Targeting DNA with triplex-forming oligonucleotides to modify gene sequence. Simon P; Cannata F; Concordet JP; Giovannangeli C Biochimie; 2008 Aug; 90(8):1109-16. PubMed ID: 18460344 [TBL] [Abstract][Full Text] [Related]
17. Sequence and pH effects of LNA-containing triple helix-forming oligonucleotides: physical chemistry, biochemistry, and modeling studies. Sun BW; Babu BR; Sørensen MD; Zakrzewska K; Wengel J; Sun JS Biochemistry; 2004 Apr; 43(14):4160-9. PubMed ID: 15065859 [TBL] [Abstract][Full Text] [Related]
18. Targeted gene knockout by 2'-O-aminoethyl modified triplex forming oligonucleotides. Puri N; Majumdar A; Cuenoud B; Natt F; Martin P; Boyd A; Miller PS; Seidman MM J Biol Chem; 2001 Aug; 276(31):28991-8. PubMed ID: 11389147 [TBL] [Abstract][Full Text] [Related]
19. Cell cycle modulation of gene targeting by a triple helix-forming oligonucleotide. Majumdar A; Puri N; Cuenoud B; Natt F; Martin P; Khorlin A; Dyatkina N; George AJ; Miller PS; Seidman MM J Biol Chem; 2003 Mar; 278(13):11072-7. PubMed ID: 12538585 [TBL] [Abstract][Full Text] [Related]
20. Triplex targets in the human rhodopsin gene. Perkins BD; Wilson JH; Wensel TG; Vasquez KM Biochemistry; 1998 Aug; 37(32):11315-22. PubMed ID: 9698379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]